Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

NCT00161785 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
340
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer